Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Chinese Patent Office
Johnson and Johnson
Chubb
McKesson
Covington
Cipla
Teva

Generated: April 26, 2018

DrugPatentWatch Database Preview

ESCITALOPRAM OXALATE Drug Profile

« Back to Dashboard

When do Escitalopram Oxalate patents expire, and when can generic versions of Escitalopram Oxalate launch?

Escitalopram Oxalate is a drug marketed by Mylan Pharms Inc, Amneal Pharms, Antrim Pharms Llc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Silarx Pharms Inc, Taro, Accord Hlthcare, Apotex Inc, Hikma Pharms, Invagen Pharms, Jubilant Generics, Lupin Ltd, Prinston Inc, Sti Pharma Llc, Teva Pharms Usa, Torrent Pharms Ltd, and Zydus Pharms Usa Inc. and is included in twenty-three NDAs.

The generic ingredient in ESCITALOPRAM OXALATE is escitalopram oxalate. There are twenty-six drug master file entries for this compound. Sixty-two suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the escitalopram oxalate profile page.
Summary for ESCITALOPRAM OXALATE
Drug patent expirations by year for ESCITALOPRAM OXALATE
Pharmacology for ESCITALOPRAM OXALATE
Synonyms for ESCITALOPRAM OXALATE
(+)-(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate
(+)-(S)-Citalopram oxalate
(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Ethanedioate
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; oxalic acid
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile; oxalic acid
(S)-(+)-Citalopram Oxalate
(S)-(+)Citalopram oxalate
(S)-1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate
(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate
(S)-Citalopram Oxalate
219861-08-2
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1)
5U85DBW7LO
861E082
AB0012102
AC-6770
AC1L3TGZ
AK138215
AKOS016340275
AN-13009
AN-9671
AOB4715
AX8019428
BG0433
C22H23FN2O5
CAS-219861-08-2
cc-372
CCG-39559
CHEMBL1200322
Cipralex
Citalopram Oxalate
CPD000469191
CS-2054
D02567
DSSTox_CID_26003
DSSTox_GSID_46003
DSSTox_RID_81282
DTXSID1046003
E0958
Entact
Escitalopram (oxalate)
Escitalopram for system suitability, EuropePharmacopoeia (EP) Reference Standard
Escitalopram oxalate (JAN/USAN)
Escitalopram oxalate [USAN:USP]
Escitalopram oxalate [USAN]
escitalopram oxalate inn
Escitalopram oxalate, >=98% (HPLC), powder
Escitalopram oxalate, EuropePharmacopoeia (EP) Reference Standard
Escitalopram oxalate, United States Pharmacopeia (USP) Reference Standard
FT-0650410
Gaudium
HMS2051D11
HMS2231M16
HMS3370I17
HMS3393D11
HY-14258A
J90016
KS-1263
KTGRHKOEFSJQNS-BDQAORGHSA-N
Lexapro
Lexapro (TN)
LS-183519
Lu 26-054-0
Lu-26-054-0
LU-260540
MFCD06407826
MLD-55
MLS001401408
MolPort-003-666-613
NC00194
NCGC00095903-01
NCGC00178555-02
NSC-758934
NSC758934
Pharmakon1600-01505216
S-(+)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate
S-(+)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate
S-(+)-5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, oxalate
S-(+)-Citalopram oxalate
SAM001246668
SCHEMBL35123
SMR000469191
SPECTRUM1505216
ST24046691
TL8001823
Tox21_111535
Tox21_111535_1
UNII-5U85DBW7LO
UNII-B5RDX2419X component KTGRHKOEFSJQNS-BDQAORGHSA-N

US Patents and Regulatory Information for ESCITALOPRAM OXALATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078032-001 Aug 28, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 078169-001 Sep 11, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 076765-003 Mar 14, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sti Pharma Llc ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 077512-002 Sep 12, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cipla
Covington
Chinese Patent Office
Accenture
Moodys
McKinsey
Chubb
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.